"Oct. 17, 2012 -- A drug used to treat psoriasis may provide a much-needed option for people with bad cases of Crohn's disease.
In the new study, some people with moderate to severe Crohn's given Stelara (ustekinumab) began to see imp"...
See Patient Package Insert. Patients should be instructed to discard bottles of Sucraid® (sacrosidase oral solution) 4 weeks after opening due to the potential for bacterial growth. For the same reason, patients should be advised to rinse the measuring scoop with water after each use. Sucraid® (sacrosidase oral solution) is fully soluble with water, milk and infant formula, but it is important to note that this product is sensitive to heat. Sucraid® (sacrosidase oral solution) should not be reconstituted or consumed with fruit juice, since its acidity may reduce the enzyme activity.
Last reviewed on RxList: 2/13/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Sucraid Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.